Probiotics may reduce risk of VAP in ICU patients

06/17/2010 | Science Blog

Daily probiotic therapy halved the risk of ventilator-associated pneumonia in a select group of patients in the intensive care unit, U.S. researchers found. The study, which used twice-daily doses of Lactobacillus rhamnosus, also showed that the treatment reduced the amount of antibiotics needed after almost five years.

View Full Article in:

Science Blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID